Macclesfield, United Kingdom

Lars Sandberg

USPTO Granted Patents = 9 


Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 40(Granted Patents)


Location History:

  • Södertälje, SE (2012 - 2013)
  • Cheshire, GB (2015)
  • Macclesfield, DE (2016)
  • Macclesfield, GB (2014 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Lars Sandberg - Pioneering BACE Inhibitors

Introduction

Lars Sandberg, a prominent inventor based in Macclesfield, GB, has made significant contributions to pharmaceutical sciences, particularly in the field of cognitive disorders. With a total of nine patents to his name, his work is pivotal in advancing treatments for Alzheimer’s disease and other related pathologies.

Latest Patents

One of Lars Sandberg's latest inventions focuses on compounds and their use as BACE inhibitors. This invention, which comprises a specific chemical formula, relates to therapeutic methods for the treatment and prevention of Aβ-related pathologies. These include Down's syndrome, β-amyloid angiopathy, and a range of cognitive impairments such as mild cognitive impairment (MCI), Alzheimer's disease, memory loss, and other neurodegenerative diseases. His innovative work aims to address not only cognitive decline but also complications associated with diseases like Parkinson’s and dementia.

Career Highlights

Currently, Lars Sandberg is associated with AstraZeneca AB, where he plays a crucial role in drug development and research. His dedication to addressing serious health issues has positioned him as an influential figure within the pharmaceutical community. His extensive patent portfolio reflects his commitment to scientific advancement and the pursuit of impactful innovations.

Collaborations

Throughout his career, Lars has collaborated with talented professionals including Karin Kolmodin and Sofia Karlstrom, contributing to various projects that aim to bring new solutions to complex medical challenges. These partnerships have not only enhanced his research but also underscored the importance of teamwork in scientific endeavors.

Conclusion

Lars Sandberg's contributions to the field of pharmaceuticals through his innovative inventions and collaborations make him a notable inventor in the realm of BACE inhibitors. As he continues to work at AstraZeneca AB, his efforts are expected to lead to further breakthroughs that could transform treatment options for patients suffering from debilitating conditions like Alzheimer’s disease and other cognitive impairments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…